KOMBINATION

European patent · EP3209778 · In force

Register entry

Publication number
EP3209778
Application number
EP15784628
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 20, 2015
Published
Aug 30, 2017
Granted
Apr 3, 2019
Protection ends at the latest
Oct 19, 2035
Next annual fee due
Oct 31, 2026
IPC classes
C12N 15/11 (2006.01)
A61K 31/7088 (2006.01)
Priority
US 201462068141 P 24.10.2014
PCT application
PCT/EP2015/074271 20.10.2015
PCT publication
WO2016/062722 28.04.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Apr 3, 2019

    Granted

    Published in Swissreg on 03.04.2019

Parties

Holder

AstraZeneca AB

Astrazeneca AB

151 85 Södertälje, SE

Inventor

LYNE, Paul Dermot

Waltham, MA 02451, US

MCCOON, Patricia Elizabeth

Waltham, MA 02451, US

WOESSNER, Richard

Waltham, MA 02451, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.